Loss of GATA6-a transcription factor that controls which genes are turned on or off-can reprogram colorectal cancer cells ...
Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, ...
A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...
Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells ...
Researchers found that loss of GATA6 reprograms colorectal cancer cells into flexible, fetal-like states that can spread to ...
A newly identified loss of cellular identity may enable colorectal cancer cells to enter a highly flexible state that ...
A global phase 2/3, randomized, open-label trial of BNT327/PM8002 in combination with chemotherapy (chemo) in first-line (1L) non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from ...
AbstractNon apoptotic cell death programs particularly ferroptosis and cuproptosis are transforming how we understand cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results